News of the move comes as the CDC’s independent panel of vaccine advisers is scheduled to meet Friday morning to discuss “additional doses in immunocompromised individuals.” Source
News of the move comes as the CDC’s independent panel of vaccine advisers is scheduled to meet Friday morning to discuss “additional doses in immunocompromised individuals.” Source